Patheon Places Big Bet with Mova Acquisition

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-01-02-2005, Volume 29, Issue 1

Patheon is betting the whole is worth more than the sum of the parts in its acquisition of Puerto Rico contract manufacturer Mova.

Related Content:

Bio/Pharma BusinessOutsourcingOutsourcing OutlookContract Manufacturing, GeneralPharmaceutical Technology-01-02-2005
Discussing the Growing Role of CDMOs with Anil Kane (DCAT 2023)
Illuminating the State of Outsourcing with Stephen Houldsworth (DCAT 2023)
Ingredion Announces Strategic Investments in India Expanding into High-Value Pharmaceutical Ingredients